Nodal modulator (NOMO) is required to sustain endoplasmic reticulum morphology.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
08 2021
Historique:
received: 07 02 2021
revised: 24 06 2021
accepted: 01 07 2021
pubmed: 6 7 2021
medline: 4 11 2021
entrez: 5 7 2021
Statut: ppublish

Résumé

The endoplasmic reticulum (ER) is a membrane-bound organelle responsible for protein folding, lipid synthesis, and calcium homeostasis. Maintenance of ER structural integrity is crucial for proper function, but much remains to be learned about the molecular players involved. To identify proteins that support the structure of the ER, we performed a proteomic screen and identified nodal modulator (NOMO), a widely conserved type I transmembrane protein of unknown function, with three nearly identical orthologs specified in the human genome. We found that overexpression of NOMO1 imposes a sheet morphology on the ER, whereas depletion of NOMO1 and its orthologs causes a collapse of ER morphology concomitant with the formation of membrane-delineated holes in the ER network positive for the lysosomal marker lysosomal-associated protein 1. In addition, the levels of key players of autophagy including microtubule-associated protein light chain 3 and autophagy cargo receptor p62/sequestosome 1 strongly increase upon NOMO depletion. In vitro reconstitution of NOMO1 revealed a "beads on a string" structure likely representing consecutive immunoglobulin-like domains. Extending NOMO1 by insertion of additional immunoglobulin folds results in a correlative increase in the ER intermembrane distance. Based on these observations and a genetic epistasis analysis including the known ER-shaping proteins Atlastin2 and Climp63, we propose a role for NOMO1 in the functional network of ER-shaping proteins.

Identifiants

pubmed: 34224731
pii: S0021-9258(21)00737-7
doi: 10.1016/j.jbc.2021.100937
pmc: PMC8327139
pii:
doi:

Substances chimiques

SQSTM1 protein, human 0
Sequestosome-1 Protein 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

100937

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM114401
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM126835
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007223
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Catherine Amaya (C)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.

Christopher J F Cameron (CJF)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.

Swapnil C Devarkar (SC)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.

Sebastian J H Seager (SJH)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.

Mark B Gerstein (MB)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA; Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, USA; Department of Computer Science, Yale University, New Haven, Connecticut, USA; Department of Statistics and Data Science, Yale University, New Haven, Connecticut, USA.

Yong Xiong (Y)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.

Christian Schlieker (C)

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA; Department of Cell Biology, Yale School of Medicine, New Haven, Connecticut, USA. Electronic address: christian.schlieker@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH